Pfizer Vaccine

Spread the love

Pfizer Vaccine

Pfizer Vaccine

The Pfizer vaccine which can be officially called BNT162b2 is an mRNA type of vaccine manufactured by Pfizer, Inc., and BioNTech against the covid-19 virus. Pfizer vaccine recommended a number of shots to be 2 shots, 21 days apart, and meant to be administered in the muscle of the upper arm.

The Pfizer vaccine does not contain Eggs, preservatives, latex. Pfizer vaccine can be used for people aged 16 years and older but should not be used on persons who have suffered a severe allergic reaction (anaphylaxis) or any sudden allergic reaction—even if it was not severe—to any ingredient in an mRNA COVID-19 vaccine (such as polyethylene glycol). Such a person shouldn’t get an mRNA COVID-19 vaccine.

For the Pfizer vaccine allergies, such allergic reaction is considered severe when there is an immediate allergic reaction within 4 hours of getting vaccinated. Pfizer symptoms can come in signs like hives, swelling, or wheezing (respiratory distress). Such Pfizer symptom scenario would need an immediate response in the hospital, and further treatment with epinephrine or EpiPen.

The side effects of the Pfizer vaccine in the arm where you got the shot are usually Pain, redness, and swelling while Pfizer’s general side effects are tiredness, headache, muscle pain, chills, fever, nausea. Note that Pfizer side effects usually begin within a day or two of being administered the vaccine which could affect your response to daily, normal activities but usually fade away in days to come.

Summary of safety Pfizer vaccine data

Vaccines in 2021

This part summarizes a safe data of the administration Pfizer vaccine;

  • The Pfizer vaccine trials carried out in clinical slated the reactogenicity side effects to having happened within 7 days of getting vaccinated but were common but were mild enough to be controlled.
  • Pfizer vaccine side effects were majorly fever, chills, tiredness, and headache throughout the body were more common after the second dose of the vaccine.
  • A good number of Pfizer vaccine side effects were mild enough to control. However, a small number of people had severe side effects, which was considered a person’s inability to carry out daily activities.
  • Our Pfizer vaccine data also confirmed that a few people in the clinical trials were rushed to the hospital while some died. The data suggest that people who got the Pfizer-BioNTech vaccine were less likely to have these more serious outcomes compared to people who got the saline placebo.

Information on how effective Pfizer-BioNTech vaccine is;

Based on succinct data from Pfizer vaccine clinical trials, the vaccine was 95% effective in the prevention of laboratory-confirmed COVID-19 illness, especially for persons without evidence of the previous infection.

Pfizer-BioNTech vaccine demographic information in Phase 2 and 3 clinical trials were persons from the following racial and ethnic categories:

81.9% White

26.2% Hispanic/Latino

9.8% African American

4.4% Asian

<3% other races/ethnicities

Age and sex breakdown:

50.6% male

49.4% female

21.4% 65 years and older​

Regular and frequent underlying medical conditions were;

Obesity (35.1%)

Diabetes (8.4%)

Pulmonary disease (7.8%)

A sneak-peak to the Israelian study on the administration of Pfizer vaccine

Lately, a professional team of Israeli researchers confirmed that Covid-19 infections had a great reduction by 75 percent after the first dose administration of the first dose of Pfizer vaccine.

According to the published Pfizer vaccine data in the peer-reviewed Lancet medical journal, the study was centered on around 9,000 Sheba healthcare workers, and about 7,000 received their first dose in January 2021.

Data confirmation from Sheba Medical Center said that between 15-28 days after Pfizer vaccination, there was a 75 percent decrease in all infections and an 85 percent reduction in symptomatic infections.

According to Gili Regev-Yochai, director of the hospital’s Infectious Disease Epidemiology Unit, ‘only 170 people became infected during the two-week period. Of those who contracted the virus, 99 showed symptoms. Eighty-nine of the sick were unvaccinated. Further discuss with her is that the hospital is now completing research on the impact of the second dose, which she said researchers still believe is essential.

Gili Regev-Yochai noted that the research supports the UK government’s decision to spread out the time between the first and second shots of the vaccine in order to inoculate more people. A shortened data finding is that the hospital workers under the age of 65 were healthier than the rest of the population, which connotes the possibility that fewer people got sick or showed symptoms for that reason.

Leave a Reply

Your email address will not be published. Required fields are marked *